1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc.

CGEM
Cullinan Therapeutics, Inc.US flagNASDAQ Global Select
20.45
USD
-0.14
- -
1.26BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
19
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
19
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
-19
- -
- -
- -
- -
- Operating Expenses
15
22
60
87
132
191
197
242
+ Selling, General & Admin
5
5
17
29
40
42
54
54
+ Research & Development
10
17
43
58
92
148
143
187
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-15
-22
-60
-68
-132
-191
-197
-242
- Non-Operating (Income) Loss
- -
-1
-1
- -
-283
-21
-29
-22
+ Interest Expense, Net
- -
-1
-1
- -
-7
-22
-30
-22
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
1
1
- -
7
22
30
22
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
-277
- -
- -
- -
Pretax Income
-14
-22
-59
-67
151
-169
-167
-220
- Income Tax Expense (Benefit)
- -
- -
- -
- -
42
-14
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-14
-22
-59
-67
109
-155
-168
-220
- Net Extraordinary Losses (Gains)
- -
-2
-15
-4
-4
-4
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
-2
-15
-4
-4
-4
- -
- -
Income (Loss) Incl. MI
-14
-20
-44
-64
113
-151
-167
-220
- Minority Interest
- -
1
8
2
2
2
- -
- -
Net Income, GAAP
-14
-21
-52
-66
111
-153
-167
-220
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-14
-21
-52
-66
111
-153
-167
-220
EBIT
-15
-22
-60
-68
-132
-191
-197
-242
EBITDA
-15
-22
-60
-68
-132
-190
-197
-241
EBITDA Margin (%)
- -
- -
- -
-358.45
- -
- -
- -
- -
EBITA
-15
-22
-60
-68
-132
-191
-197
-242
Gross Margin (%)
- -
- -
- -
100
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
-358.73
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-346.14
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
11
19
41
43
45
42
54
59
Basic EPS, GAAP
-1.24
-1.07
-1.25
-1.52
2.46
-3.69
-3.11
-3.73
Basic EPS from Cont Ops
-1.24
-1.12
-1.44
-1.57
2.42
-3.73
-3.12
-3.73
Diluted Weighted Avg Shares
11
19
41
43
47
42
54
59
Diluted EPS, GAAP
-1.24
-1.07
-1.25
-1.52
2.38
-3.69
-3.11
-3.73
Diluted EPS from Cont Ops
-1.24
-1.12
-1.44
-1.57
2.34
-3.73
-3.12
-3.73

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
34
100
212
297
474
480
415
387
+ Cash, Cash Equivalents & STI
34
99
210
290
467
467
399
378
+ Cash & Cash Equivalents
34
63
168
60
156
98
83
88
+ ST Investments
- -
35
42
231
311
369
316
290
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
2
6
7
13
16
9
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
2
141
87
4
207
62
+ Property, Plant & Equip, Net
- -
- -
- -
- -
5
4
2
3
+ Property, Plant & Equip
- -
- -
- -
- -
5
4
3
4
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
140
81
- -
204
58
+ LT Investments
- -
- -
- -
140
81
- -
204
58
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
2
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
2
- -
- -
- -
- -
- -
Total Assets
35
100
215
437
561
484
622
448
+ Payables & Accruals
1
2
13
8
14
19
18
26
+ Accounts Payable
- -
1
10
3
3
2
2
1
+ Accrued Taxes
- -
- -
- -
- -
4
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
3
5
7
16
16
25
+ ST Debt
- -
- -
- -
- -
2
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
1
1
1
+ Other ST Liabilities
- -
1
2
4
6
8
11
11
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
2
4
6
8
11
11
Total Current Liabilities
1
3
14
12
22
28
31
38
+ LT Debt
- -
- -
- -
- -
4
2
1
2
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
4
2
1
2
+ Other LT Liabilities
54
138
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
54
138
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
54
138
- -
- -
4
2
1
2
Total Liabilities
55
140
14
12
26
30
31
40
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
292
585
585
655
959
996
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
292
585
585
655
959
996
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-21
-42
-93
-159
-48
-201
-368
-588
+ Other Equity
- -
- -
- -
-1
-3
- -
- -
1
Equity Before Minority Interest
-21
-41
199
425
535
454
590
409
+ Minority/Non Controlling Interest
- -
1
1
- -
- -
- -
- -
- -
Total Equity
-21
-40
200
425
535
454
590
409
Total Liabilities & Equity
35
100
215
437
561
484
622
448
Shares Outstanding
38
41
41
44
46
43
59
60
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
5
4
2
3
Net Debt
-34
-63
-168
-60
-156
-98
-83
-88
Net Debt to Equity
163.84
158.49
-83.97
-14.05
-29.15
-21.69
-14.06
-21.61
Tangible Common Equity Ratio
-59.62
-40.59
92.69
97.21
95.35
93.71
94.93
91.16
Current Ratio
25.85
39.67
14.82
25.25
21.09
17.07
13.53
10.25
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-14
-22
-59
-67
109
-155
-168
-220
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
23
28
-247
21
22
30
+ Stock-Based Compensation
- -
- -
15
24
28
30
38
36
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
8
3
-275
-10
-15
-6
+ Chg in Non-Cash Work Cap
- -
- -
7
-4
11
- -
- -
14
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
-3
-1
-6
-2
7
+ Inc (Dec) in Accts Payable
- -
1
7
- -
12
6
2
7
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-14
-21
-30
-43
-127
-134
-145
-176
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
-1
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
145
267
- -
38
263
- -
+ Increase in Capital Stock
- -
- -
145
267
- -
38
263
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-35
-7
-334
-25
36
-136
180
+ Dec in LT Investment
- -
- -
63
192
353
409
585
417
+ Inc in LT Investment
- -
-35
-70
-526
-378
-373
-721
-237
+ Net Cash From Acq & Div
- -
- -
1
- -
275
- -
- -
- -
+ Cash from Divestitures
- -
- -
1
- -
275
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-35
-5
-334
249
36
-136
180
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
2
- -
- -
+ Cash From Debt
- -
- -
- -
- -
2
2
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
-2
- -
- -
- -
+ Other Financing Activities
- -
86
-5
2
-26
1
4
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
86
140
269
-26
41
266
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-14
29
105
-108
96
-58
-15
5
EBITDA
-15
-22
-60
-68
-132
-190
-197
-241
EBITDA Margin (%)
- -
- -
- -
-358.45
- -
- -
- -
- -
Free Cash Flow
-14
-21
-30
-43
-128
-134
-145
-176
Net Cash Paid for Acquisitions
- -
- -
-1
- -
-275
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
-128
- -
- -
- -
Free Cash Flow to Equity
- -
-21
-30
-43
-128
-133
-145
-176
Free Cash Flow per Basic Share
-1.21
-1.08
-0.72
-1.01
-2.83
-3.24
-2.7
-2.98
Price/Free Cash Flow
- -
- -
- -
-15.3
-3.92
-3.16
-4.51
-3.48
Cash Flow to Net Income
0.95
1.01
0.57
0.66
-1.14
0.88
0.87
0.8
Capital Expenditures
- -
- -
- -
- -
-1
- -
- -
- -